🇺🇸 FDA
Pipeline program

PROPESS 10 mg, système de diffusion vaginal, PROSTINE E2 2 mg/3 g, gel vaginal, ANGUSTA 25 microgrammes, comprime, OXYTOCINE PANPHARMA 5 UI/1 ml, solution injectable

DR200090

Approved small_molecule active

Quick answer

PROPESS 10 mg, système de diffusion vaginal, PROSTINE E2 2 mg/3 g, gel vaginal, ANGUSTA 25 microgrammes, comprime, OXYTOCINE PANPHARMA 5 UI/1 ml, solution injectable for Labor Induction of women with an unfavorable Cervix after 24 hours of cervical ripening is a Approved program (small_molecule) at Tour Hekla with 1 ClinicalTrials.gov record(s).

Program details

Company
Tour Hekla
Indication
Labor Induction of women with an unfavorable Cervix after 24 hours of cervical ripening
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials